Merck Drug Shown to Work in Treating Male Osteoporosis

Article

According to a study in the New England Journal of Medicine, Merck & Co.'s Fosamax drug, primarily used for the treatment of osteoporosis in women, is also useful in treating the disease in men. The two-year study, led by a team of researchers from the Oregon Health Sciences University, found that the drug was effective in increasing bone density in men, particularly in the spine and hip. Merck announced earlier this year that it is seeking approval from the US Food and Drug Administration to sell the drug to men. For more information, visit www.merck.com.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
Jill Holdsworth, MS, CIC, FAPIC, NREMT, CRCST, CHL, an infection preventionist from Atlanta, Georgia.  (Photo credit: Tori Whitacre Martonicz)
"Top 5" in a blue ribbon  (Adobe Stock 235182652 by Evgeny)
Bug of the Month
© 2025 MJH Life Sciences

All rights reserved.